Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30… EP News Bureau Feb 4, 2021 Biocon Biologics, a subsidiary of Biocon has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand…
Biocon and Mylan launch fulphila — biosimilar to pegfilgrastim, in Canada EP News Bureau Apr 28, 2020 The approval of fulphila was based on a comprehensive package of analytical, non-clinical and clinical data, which confirmed that…
